Literature DB >> 1735898

Valvular reflux after deep vein thrombosis: incidence and time of occurrence.

A Markel1, R A Manzo, R O Bergelin, D E Strandness.   

Abstract

From December 1986 to December 1990, 268 patients with acute deep vein thrombosis were studied in our laboratory. From this group 107 patients (123 legs with deep vein thrombosis) were placed in our long-term follow-up program. The documentation of valvular reflux and its site was demonstrated by duplex scanning. The duplex studies were done at intervals of 1 and 7 days, 1 month, every 3 months for the first year, and then yearly thereafter. The mean follow-up time for these patients was 341 days. In addition, reflux was evaluated in 502 patients with negative duplex study results and no previous history of deep vein thrombosis or chronic venous insufficiency. In the patients with acute deep vein thrombosis, valvular incompetence was noted in 17 limbs (14%) at the time of the initial study. Reflux was absent in 106 limbs (86%). In this last group reflux developed in 17% of the limbs by day 7. By the end of the first month, 37% demonstrated reflux. By the end of the first year, more than two thirds of the involved limbs had developed valvular incompetence. The distribution of reflux at the end of the first year of follow-up was the following: (1) popliteal vein, 58%; (2) superficial femoral vein, 37%; (3) greater saphenous vein, 25%; and (4) posterior tibial vein, 18%. Reflux seems to be more frequent in the segments previously affected with deep vein thrombosis. Among cases where segments were initially affected with thrombi, after 1 year the incidence of reflux was 53%, 44%, 59%, and 33% for the common femoral vein, superficial femoral, popliteal vein, and posterior tibial vein, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1735898

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  29 in total

1.  Iliocaval vein stenting: Long term survey of postthrombotic symptoms and working capacity.

Authors:  Alaa Alhadad; Tilo Kölbel; Andreas Herbst; Jan Holst; Hussein Alhadad; Anders Gottsäter
Journal:  J Thromb Thrombolysis       Date:  2011-02       Impact factor: 2.300

Review 2.  The post-thrombotic syndrome: the forgotten morbidity of deep venous thrombosis.

Authors:  Susan R Kahn
Journal:  J Thromb Thrombolysis       Date:  2006-02       Impact factor: 2.300

Review 3.  The postthrombotic syndrome.

Authors:  Raffaele Pesavento; Sabina Villalta; Paolo Prandoni
Journal:  Intern Emerg Med       Date:  2009-12-10       Impact factor: 3.397

Review 4.  Lower extremity venous reflux.

Authors:  Vinit Baliyan; Shahein Tajmir; Sandeep S Hedgire; Suvranu Ganguli; Anand M Prabhakar
Journal:  Cardiovasc Diagn Ther       Date:  2016-12

5.  Acute deep vein thrombosis cases in the real world.

Authors:  Seth J Klein; Suresh Vedantham
Journal:  Semin Intervent Radiol       Date:  2012-03       Impact factor: 1.513

6.  Multifaceted management of the postthrombotic syndrome.

Authors:  Lina Nayak; Suresh Vedantham
Journal:  Semin Intervent Radiol       Date:  2012-03       Impact factor: 1.513

Review 7.  Treating infrainguinal deep venous thrombosis.

Authors:  Suresh Vedantham
Journal:  Tech Vasc Interv Radiol       Date:  2014-06

Review 8.  Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors.

Authors:  Neil A Goldenberg; Marco P Donadini; Susan R Kahn; Mark Crowther; Gili Kenet; Ulrike Nowak-Göttl; Marilyn J Manco-Johnson
Journal:  Haematologica       Date:  2010-06-30       Impact factor: 9.941

9.  Catheter-directed thrombolysis to avoid late consequences of acute deep vein thrombosis.

Authors:  Suresh Vedantham
Journal:  Thromb Res       Date:  2017-08-18       Impact factor: 3.944

10.  Venous claudication in iliofemoral thrombosis: long-term effects on venous hemodynamics, clinical status, and quality of life.

Authors:  Konstantinos T Delis; Dimitris Bountouroglou; Averil O Mansfield
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.